XML 39 R24.htm IDEA: XBRL DOCUMENT v3.22.0.1
Accumulated Other Comprehensive Income
 12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Accumulated Other Comprehensive Income Accumulated Other Comprehensive Income
As of December 31, 2021 and 2020, the only component of accumulated other comprehensive income related to the Unrealized gains on available for sale debt securities on the Series A Biohaven Preferred Shares. As a result of the termination of interest rate swaps in February 2020, all amounts associated with interest rate swaps previously designated as cash flow hedges and recorded in Accumulated other comprehensive income were released into earnings.

The components of accumulated other comprehensive income as of December 31, 2021 and 2020 are as follows (in thousands):
Unrealized Gains on Available for Sale Debt SecuritiesUnrealized Losses on Interest Rate SwapsTotal Accumulated Other Comprehensive Income
Balance at December 31, 20196,159 (4,066)2,093 
Reclassification to net income(10,921)4,066 (6,855)
Activity for the year60,617 — 60,617 
Reclassification to non-controlling interest(24,022)— (24,022)
Reclassification from non-controlling interest2,562 — 2,562 
Balance at December 31, 202034,395 — 34,395 
Reclassification to net income(28,481)— (28,481)
Activity for the year6,335 — 6,335 
Reclassification from non-controlling interest4,242 — 4,242 
Balance at December 31, 2021$16,491 $— $16,491 

The total reclassification of unrealized gains on available for sale debt securities of $50.9 million in the year ended December 31, 2021 is presented within Interest income on the consolidated statements of operations, including $28.5 million attributable to controlling interest noted in the table above and $22.4 million attributable to the non-controlling interest. The total reclassification of unrealized gains on available for sale debt securities of $20.6 million in the year ended December 31, 2020 is presented within Interest income on the consolidated statements of operations, including $10.9 million attributable to controlling interest noted in the table above and $9.6 million attributable to the non-controlling interest.